These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7861695)

  • 1. Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney model.
    Griffin KA; Picken M; Bidani AK
    Kidney Int; 1994 Oct; 46(4):1010-8. PubMed ID: 7861695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
    Griffin KA; Picken MM; Bakris GL; Bidani AK
    Kidney Int; 1999 May; 55(5):1849-60. PubMed ID: 10231447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat.
    Griffin KA; Picken MM; Bidani AK
    Kidney Int; 2004 Jan; 65(1):209-18. PubMed ID: 14675052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model.
    Bidani AK; Griffin KA; Picken M; Lansky DM
    Am J Physiol; 1993 Sep; 265(3 Pt 2):F391-8. PubMed ID: 8214098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive drugs on glomerular morphology.
    Yoshida Y; Kawamura T; Ikoma M; Fogo A; Ichikawa I
    Kidney Int; 1989 Oct; 36(4):626-35. PubMed ID: 2554053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model.
    Griffin KA; Picken MM; Bakris G; Bidani AK
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S191-S195. PubMed ID: 28095249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antihypertensive drugs on the progress of renal failure in hyperlipidemic Imai rats.
    Sakemi T; Baba N
    Nephron; 1993; 63(3):323-9. PubMed ID: 8446271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.
    Adamczak M; Gross ML; Krtil J; Koch A; Tyralla K; Amann K; Ritz E
    J Am Soc Nephrol; 2003 Nov; 14(11):2833-42. PubMed ID: 14569093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
    Nabokov A; Amann K; Wagner J; Gehlen F; Münter K; Ritz E
    Nephrol Dial Transplant; 1996 Mar; 11(3):514-20. PubMed ID: 8671823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury.
    Anderson S; Rennke HG; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S242-4. PubMed ID: 3553475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of renal function in the rat remnant kidney model of chronic renal failure by blood pressure reduction.
    Jackson B; Debrevi L; Cubela R; Whitty M; Johnston CI
    Clin Exp Pharmacol Physiol; 1986 Apr; 13(4):319-23. PubMed ID: 3731536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
    Raij L; Chiou XC; Owens R; Wrigley B
    Am J Med; 1985 Sep; 79(3C):37-41. PubMed ID: 2996345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys.
    Griffin KA; Picken MM; Bidani AK
    J Clin Invest; 1995 Aug; 96(2):793-800. PubMed ID: 7635974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxic serum nephritis with hypertension: amelioration by antihypertensive therapy.
    Neugarten J; Kaminetsky B; Feiner H; Schacht RG; Liu DT; Baldwin DS
    Kidney Int; 1985 Aug; 28(2):135-9. PubMed ID: 3834224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury.
    Griffin KA; Picken M; Bidani AK
    J Am Soc Nephrol; 1994 Jun; 4(12):2023-31. PubMed ID: 7919155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation.
    Bidani AK; Griffin KA; Bakris G; Picken MM
    Kidney Int; 2000 Apr; 57(4):1651-61. PubMed ID: 10760100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
    Dworkin LD; Benstein JA; Parker M; Tolbert E; Feiner HD
    Kidney Int; 1993 Apr; 43(4):808-14. PubMed ID: 8479116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases.
    Boffa JJ; Lu Y; Placier S; Stefanski A; Dussaule JC; Chatziantoniou C
    J Am Soc Nephrol; 2003 May; 14(5):1132-44. PubMed ID: 12707384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.